account_balance
Investment manager · 13F filer · SEC CIK 1937964
Artia Global Partners LP
Reported value$526Mas of Jun 30, 2026
Positions47 6 new, 7 sold out
Top 10 weight66.5%ABVX alone is 13%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
ABVXAbivax S.A.
13.1%Trimmed −14%
INSMInsmed Inc
11.9%Trimmed −6%
TRVITrevi Therapeutics, Inc.
7.8%Added +10%
BTSGBrightSpring Health Services, Inc.
6.9%Added +862%
RVMDRevolution Medicines, Inc.
6.6%Added +48%
ARGXArgenx SE
5.2%
ALKSAlkermes PLC.
4.5%New
TVTXTravere Therapeutics, Inc.
3.7%Added +380%
AZNAstrazeneca PLC
3.5%+3%
NAMSNewAmsterdam Pharma Co N.V.
3.2%
DNTHDianthus Therapeutics, Inc.
3.0%
DGXQuest Diagnostics Inc
2.6%+60%
ABVXAbivax S.A.
13.1%Trimmed −14%
INSMInsmed Inc
11.9%Trimmed −6%
TRVITrevi Therapeutics, Inc.
7.8%
BTSGBrightSpring Health Services, Inc.
6.9%
RVMDRevolution Medicines, Inc.
6.6%+48%
ARGXArgenx SE
5.2%
ALKSAlkermes PLC.
4.5%
TVTXTravere Therapeutics, Inc.
3.7%
AZN3.5%NAMSDNTH3.0%DGX2.6%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
ABVX Abivax S.A. 13.1% Trimmed −14%INSM Insmed Inc 11.9% Trimmed −6%TRVI Trevi Therapeutics, Inc. 7.8% Added +10%BTSG BrightSpring Health Services, Inc. 6.9% Added +862%RVMD Revolution Medicines, Inc. 6.6% Added +48%ARGX Argenx SE 5.2% HeldALKS Alkermes PLC. 4.5% NewTVTX Travere Therapeutics, Inc. 3.7% Added +380%AZN Astrazeneca PLC 3.5% Added +3%NAMS NewAmsterdam Pharma Co N.V. 3.2% HeldDNTH Dianthus Therapeutics, Inc. 3.0% HeldDGX Quest Diagnostics Inc 2.6% Added +60%
What changed
Biggest moves since Mar 31, 2026
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.